Genome-based diagnostics : clarifying pathways to clinical use : workshop summary / Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Introduction -- Calls for Change -- Test Developers -- Patients -- Payers -- Regulation, Reimbursement, and Public Health -- Discussion of Major Proposals -- References -- Appendix A: Workshop Agenda -- Appendix B: Speaker Biographical Sketches -- Appendix C: Statement of Task -- Appendix D: Registered Attendees
Summary
The Roundtable on Translating Genomic-Based Research for Health held a follow-up workshop on November 15, 2011 titled Facilitating Development and Utilization of Genome-Based Diagnostic Technologies to further explore the differences in evidence required for clinical use, regulatory oversight, guideline inclusion, coverage, and reimbursement of genomic diagnostic tests among stakeholders with the goal of clarifying a pathway for successfully bringing tests to clinical use for the benefit of patients. Presenters at the workshop were asked to consider four broad issues:1. How are the barriers to successful genomic test development viewed?2. What are potential solutions?3. What are the obstacles to achieving those solutions?4. How can those obstacles be overcome?
Bibliography
Includes bibliographical references
Notes
Title from PDF title page (viewed October 26, 2012)
